Influenza Vaccination Blunts the Inflammatory Response in Patients Undergoing Cardiopulmonary Bypass
Authors:
- 1 June 2021
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 111 (6) , 1923-1930
Abstract
No abstract availableKeywords
Funding Information
- Merck
- Northern Ontario Academic Medicine Association
- Pfizer
- Sanofi Pasteur
This publication has 36 references indexed in Scilit:
- Inflammation in Atrial FibrillationJACC, 2012
- Influenza vaccination reduces cardiovascular events in patients with acute coronary syndromeEuropean Heart Journal, 2011
- Role of inflammation and oxidative stress in atrial fibrillationHeart Rhythm, 2010
- Inflammatory response and cardioprotection during open‐heart surgery: the importance of anaestheticsBritish Journal of Pharmacology, 2008
- Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD studyEuropean Heart Journal, 2008
- Influenza Vaccination as Secondary Prevention for Cardiovascular DiseaseCirculation, 2006
- Increased Interleukin-6 After Cardiac Surgery Predicts InfectionAnesthesia & Analgesia, 2006
- Hemofiltration but Not Steroids Results in Earlier Tracheal Extubation following Cardiopulmonary BypassAnesthesiology, 2004
- Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of ϵ-aminocaproic acid and aprotininThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Inflammatory response to cardiopulmonary bypassThe Annals of Thoracic Surgery, 1993